Ascariasis medical therapy: Difference between revisions
Jump to navigation
Jump to search
Line 13: | Line 13: | ||
# [[Ivermectin]] 150 to 200 µg/kg PO single dose | # [[Ivermectin]] 150 to 200 µg/kg PO single dose | ||
# [[Nitazoxanide]] 500 mg bid for 3 days | # [[Nitazoxanide]] 500 mg bid for 3 days | ||
# [[Levamisole]] 150 mg PO single dose. The pediatric dose is 2.5 mg/kg | # [[Levamisole]] 150 mg PO single dose. The pediatric dose is 2.5 mg/kg PO daily | ||
# [[Pyrantel]] Pamoate 11 mg/kg single dose PO - maximum 1.0 g | # [[Pyrantel]] Pamoate 11 mg/kg single dose PO - maximum 1.0 g | ||
# [[Piperazine citrate]] 75 mg/kg qd for 2 days - maximum 3.5 g | # [[Piperazine citrate]] 75 mg/kg qd for 2 days - maximum 3.5 g |
Revision as of 14:12, 6 March 2017
Ascariasis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Ascariasis medical therapy On the Web |
American Roentgen Ray Society Images of Ascariasis medical therapy |
Risk calculators and risk factors for Ascariasis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Fatimo Biobaku M.B.B.S [2]
Overview
Medical Therapy
Antimicrobial Regimen for Ascariasis[1][2][3][4]
- Preferred regimen
- Albendazole 400 mg PO single dose. Albendazole dose for children between the ages of 1-2 years is 200 mg.
- Mebendazole 500 mg PO single dose or 100 mg bid for 3 days
- Alternative regimen
- Ivermectin 150 to 200 µg/kg PO single dose
- Nitazoxanide 500 mg bid for 3 days
- Levamisole 150 mg PO single dose. The pediatric dose is 2.5 mg/kg PO daily
- Pyrantel Pamoate 11 mg/kg single dose PO - maximum 1.0 g
- Piperazine citrate 75 mg/kg qd for 2 days - maximum 3.5 g
References
- ↑ Durand, Marlene (2015). "Chapter 288:Intestinal Nematodes (Roundworms)". Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases Updated Edition, Eighth Edition. Elsevier. pp. 3199–3207. ISBN 978-1-4557-4801-3.
- ↑ Centers for Disease Control and Prevention.https://www.cdc.gov/parasites/ascariasis/health_professionals/index.html#tx Accessed on the 6th of March, 2017.
- ↑ Romero Cabello R, Guerrero LR, Muñóz García MR, Geyne Cruz A (1997). "Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico". Trans R Soc Trop Med Hyg. 91 (6): 701–3. PMID 9580117.
- ↑ Khuroo MS (1996). "Ascariasis". Gastroenterol Clin North Am. 25 (3): 553–77. PMID 8863040.